Stoke Therapeutics, Inc.
NASDAQ:STOK
11.65 (USD) • At close July 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 158.569 | 22.614 | 4.894 | 4.831 | 4.216 | 2.802 | 3.308 | -2.481 | 5.152 | 3.269 | 2.905 | 3.231 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 1.108 | 1.111 | 1.11 | 1.113 | 1.215 | 1.2 | 1.167 | 1.147 | 1.152 | 0.924 | 0.835 | 0.624 | 0.621 | 0.576 | 0.526 | 0.507 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 158.569 | 21.506 | 3.783 | 3.721 | 3.103 | 1.587 | 2.108 | -3.648 | 4.005 | 2.117 | 1.981 | 2.396 | 2.376 | -0.621 | -0.576 | -0.526 | -0.507 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0.951 | 0.773 | 0.77 | 0.736 | 0.566 | 0.637 | 1.47 | 0.777 | 0.648 | 0.682 | 0.742 | 0.792 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 32.676 | 23.423 | 22.205 | 20.588 | 21.805 | 21.154 | 20.271 | 20.551 | 19.631 | 21.061 | 20.109 | 18.358 | 18.309 | 15.802 | 14.358 | 14.095 | 9.913 | 8.904 | 8.109 | 7.968 | 7.215 | 7.089 | 6.518 | 6.023 | 4.133 | 3.004 | 2.227 | 1.888 | 1.252 |
| General & Administrative Expenses
| 14.653 | 12.844 | 12.692 | 13.037 | 10.22 | 10.61 | 10.271 | 10.23 | 10.211 | 9.383 | 9.944 | 10.111 | 9.486 | 8.724 | 8.325 | 7.934 | 6.914 | 5.682 | 5.602 | 5.044 | 4.52 | 3.979 | 3.324 | 2.422 | 2.189 | 1.538 | 1.09 | 1.122 | 0.66 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -0.562 | -0.55 | -0.591 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 14.653 | 12.844 | 12.692 | 12.475 | 9.67 | 10.019 | 10.271 | 10.23 | 10.211 | 9.383 | 9.944 | 10.111 | 9.486 | 8.724 | 8.325 | 7.934 | 6.914 | 5.682 | 5.602 | 5.044 | 4.52 | 3.979 | 3.324 | 2.422 | 2.189 | 1.538 | 1.09 | 1.122 | 0.66 |
| Other Expenses
| 0 | 0 | 0 | -0.048 | -0.428 | 0.041 | 0.041 | 0.041 | 0.042 | 0.041 | 0.042 | 0.042 | 0.042 | 0.042 | 0.042 | 0.028 | 0.016 | 0.015 | 0.016 | 0.003 | 0.022 | 0.004 | 0.002 | -0.003 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 47.329 | 36.267 | 34.897 | 33.063 | 31.475 | 31.173 | 30.542 | 30.781 | 29.842 | 30.444 | 30.053 | 28.469 | 27.795 | 24.526 | 22.683 | 22.029 | 16.827 | 14.586 | 13.711 | 13.012 | 11.735 | 11.068 | 9.842 | 8.445 | 6.322 | 4.542 | 3.317 | 3.01 | 1.912 |
| Operating Income
| 111.24 | -13.653 | -30.003 | -29.342 | -28.372 | -29.586 | -27.234 | -33.262 | -20.442 | -27.175 | -27.148 | -25.238 | -24.795 | -24.526 | -22.683 | -22.029 | -16.827 | -14.586 | -13.711 | -13.012 | -11.735 | -11.068 | -9.842 | -8.445 | -6.322 | -4.542 | -3.317 | -3.01 | -1.912 |
| Operating Income Ratio
| 0.702 | -0.604 | -6.131 | -6.074 | -6.73 | -10.559 | -8.233 | 13.407 | -3.968 | -8.313 | -9.345 | -7.811 | -8.265 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.917 | 3.171 | 3.573 | 3.647 | 1.998 | 2.628 | 2.692 | 2.608 | 2.145 | 1.52 | 1.037 | 0.586 | 0.146 | 0.078 | 0.086 | 0.062 | 0.034 | 0.025 | 0.027 | 0.053 | 0.696 | 0.908 | 1.238 | 0.626 | 0.58 | 0.26 | 0 | 0 | 0 |
| Income Before Tax
| 114.157 | -10.482 | -26.43 | -25.695 | -26.374 | -26.958 | -24.542 | -30.654 | -22.545 | -25.655 | -26.111 | -24.652 | -24.649 | -24.448 | -22.597 | -21.967 | -16.793 | -14.561 | -13.684 | -12.959 | -11.039 | -10.16 | -8.604 | -7.819 | -5.742 | -4.282 | -3.317 | -3.01 | -1.912 |
| Income Before Tax Ratio
| 0.72 | -0.464 | -5.4 | -5.319 | -6.256 | -9.621 | -7.419 | 12.356 | -4.376 | -7.848 | -8.988 | -7.63 | -8.216 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 1.278 | 0 | 0 | 0 | 1.07 | 10.714 | -3.288 | -3.178 | -4.248 | -3.608 | -2.032 | -1.432 | -0.25 | -0.078 | -0.044 | -0.034 | -0.254 | -0.01 | -0.245 | -0.05 | -0.674 | -0.904 | -1.362 | -0.629 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| 112.879 | -10.482 | -26.43 | -25.695 | -26.374 | -26.958 | -24.542 | -30.654 | -18.297 | -22.047 | -24.079 | -23.22 | -24.399 | -24.448 | -22.597 | -21.967 | -16.793 | -14.561 | -13.684 | -12.959 | -11.039 | -10.16 | -8.604 | -7.819 | -5.742 | -4.282 | -3.317 | -3.01 | -1.912 |
| Net Income Ratio
| 0.712 | -0.464 | -5.4 | -5.319 | -6.256 | -9.621 | -7.419 | 12.356 | -3.551 | -6.744 | -8.289 | -7.187 | -8.133 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 1.95 | -0.18 | -0.47 | -0.46 | -0.57 | -0.6 | -0.55 | -0.69 | -0.43 | -0.56 | -0.61 | -0.59 | -0.65 | -0.66 | -0.61 | -0.6 | -0.46 | -0.44 | -0.41 | -0.39 | -0.34 | -0.31 | -0.26 | -1.54 | -0.19 | -0.18 | -0.14 | -0.13 | -0.081 |
| EPS Diluted
| 1.9 | -0.18 | -0.47 | -0.46 | -0.57 | -0.6 | -0.55 | -0.69 | -0.43 | -0.56 | -0.61 | -0.59 | -0.65 | -0.66 | -0.61 | -0.6 | -0.46 | -0.44 | -0.41 | -0.39 | -0.34 | -0.31 | -0.26 | -1.54 | -0.19 | -0.18 | -0.14 | -0.13 | -0.081 |
| EBITDA
| 111.717 | -13.127 | -30.003 | -28.794 | -27.809 | -28.962 | -26.597 | -32.651 | -24.093 | -26.567 | -26.76 | -24.936 | -24.548 | -24.291 | -22.429 | -21.78 | -16.591 | -14.349 | -13.477 | -12.788 | -11.542 | -10.929 | -9.716 | -8.34 | -6.242 | -4.467 | -3.253 | -2.967 | -1.88 |
| EBITDA Ratio
| 0.702 | -0.58 | -6.131 | -5.96 | -6.596 | -10.336 | -8.04 | 13.16 | -4.676 | -8.127 | -9.212 | -7.718 | -8.183 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |